With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is taking big steps in its strategic review that has now resulted in a leadersh | Along with the CEO transition announcement,

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and

Kenvue names interim CEO, begins strategic review to simplify operations and considers divesting smaller beauty brands amid falling sales.